U.S. Cytosine Market Size & Outlook, 2022-2030
Related Markets
U.S. cytosine market highlights
- The U.S. cytosine market generated a revenue of USD 107.6 million in 2022 and is expected to reach USD 217.9 million by 2030.
- The U.S. market is expected to grow at a CAGR of 9.2% from 2023 to 2030.
- In terms of segment, pharmaceutical was the largest revenue generating end use in 2022.
- Pharmaceutical is the most lucrative end use segment registering the fastest growth during the forecast period.
Cytosine market data book summary
| Market revenue in 2022 | USD 107.6 million |
| Market revenue in 2030 | USD 217.9 million |
| Growth rate | 9.2% (CAGR from 2023 to 2030) |
| Largest segment | Pharmaceutical |
| Fastest growing segment | Pharmaceutical |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Chemical Industry, Pharmaceutical, Agriculture, Other |
Other key industry trends
- In terms of revenue, U.S. accounted for 34.1% of the global cytosine market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. cytosine market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 27.6 million by 2030.
Pharmaceutical was the largest segment with a revenue share of 67.75% in 2022. Horizon Databook has segmented the U.S. cytosine market based on chemical industry, pharmaceutical, agriculture, other covering the revenue growth of each sub-segment from 2018 to 2030.
Cytosine finds significant demand in the pharmaceutical industry in the U.S. Its applications range from drug discovery to the development of targeted therapies. Cytosine-based compounds and nucleoside analogs are used to modulate genetic processes, target specific diseases, and improve treatment outcomes.
In the U.S., pharmaceutical companies are actively researching and developing cytosinebased nucleoside analogs to combat viral infections, such as HIV and hepatitis, and to target cancer cells selectively.
These analogs, designed with cytosine as a fundamental component, offer potential breakthroughs in disease management and personalized medicine. Furthermore, according to the European Federation of Pharmaceutical Industries and Associations, the North American pharmaceutical market, including the U.S. and Canada., remained the world’s largest market with a 49.1% of the global pharmaceutical share in 2021.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cytosine Market Scope
Cytosine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| SIELC Technologies | View profile | 11-50 | Wheeling, Illinois, United States, North America | https://www.sielc.com/ |
| Kanto | View profile | 51-100 | Portland, Oregon, United States, North America | https://kantocorp.com |
| VIVAN Life Sciences | View profile | 51-100 | Mumbai, Maharashtra, India, Asia | https://www.vivanls.com/ |
| TUOXIN | View profile | 101-250 | Xinxiang, Henan, China, Asia | http://www.tuoxinchem.com/ |
| Santa Cruz Biotechnology (SCBT) | View profile | 251-500 | Dallas, Texas, United States, North America | https://www.scbt.com/ |
| Spectrum Chemicals | View profile | 11-50 | Mumbai, Maharashtra, India, Asia | https://www.spectrumchemicals.net |
| Tokyo Chemical Industry | View profile | 501-1000 | Chennai, Tamil Nadu, India, Asia | https://www.tcichemicals.com/ |
| FUJIFILM Holdings Corp | View profile | 83784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | http://www.fujifilmholdings.com |
U.S. cytosine market size, by end use, 2018-2030 (US$M)
U.S. Cytosine Market Outlook Share, 2022 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more